Dementia Clinical Trials in the UK: A Complete Guide for 2026
Everything you need to know about dementia in the UK, including vascular dementia, Lewy body dementia, frontotemporal dementia, and mixed dementia. See treatment approaches from early intervention to symptom management and where trials fit in.
Why Dementia Clinical Trials Matter
Clinical trials are essential for developing new treatments for dementia. They test whether new drugs, devices, or approaches are safe and effective before they become widely available. In the UK, the NHS actively participates in trials across hundreds of hospitals and research centres, making it one of the best places in the world to access cutting-edge treatments.
For dementia patients, trials can offer access to treatments that are not yet available on the NHS, close monitoring by specialist teams, and the opportunity to contribute to medical knowledge that helps future patients.
Current Treatment Landscape
Standard treatment for dementia follows established pathways based on disease stage and individual patient factors. For vascular dementia, the standard approach is blood pressure management, antiplatelet therapy, lifestyle changes. For lewy body dementia, the standard approach is cholinesterase inhibitors, physical therapy, symptom management. For frontotemporal dementia, the standard approach is behavioural management, speech therapy, ssris for behavioural symptoms. For mild cognitive impairment, the standard approach is cognitive stimulation, lifestyle interventions, monitoring.
What Types of Trials Are Available?
Anti-Amyloid & Anti-Tau
While most approved for Alzheimer's, some trials are testing whether these drugs benefit other forms of dementia, particularly mixed dementia with amyloid pathology.
Vascular Protection
Trials testing intensive blood pressure management, anti-inflammatory drugs, and lifestyle interventions to slow vascular dementia progression.
Neuroinflammation Targets
Emerging drugs targeting brain inflammation (TSPO, microglial activation) that may slow multiple types of dementia.
Digital Therapeutics
Cognitive training apps, VR-based rehabilitation, and AI-driven monitoring tools being tested to maintain cognitive function and independence.
Who Can Join a Dementia Trial?
Eligibility criteria vary between trials, but common factors include:
- A confirmed diagnosis of dementia
- Being at a specific disease stage or treatment line
- Age requirements (most adult trials accept 18+)
- No conflicting medical conditions or medications
- Willingness to attend regular hospital visits
Your specialist can help determine which trials you may be eligible for. You can also use our Smart Matcher tool to find trials based on your specific profile.
How to Find Dementia Trials Near You
There are several ways to find clinical trials for dementia in the UK:
- TrialConnect: Use our Dementia condition page to search all recruiting trials, or try the Smart Matcher for personalised matching.
- NHS Be Part of Research: The NHS maintains a searchable database of clinical trials at research sites across the UK.
- Your Specialist: Ask your consultant or clinical nurse specialist about trials at your hospital or local research network.
- NIHR Clinical Research Network: The National Institute for Health Research coordinates trials across England, with equivalent networks in Scotland, Wales, and Northern Ireland.
Frequently Asked Questions
What is the difference between dementia and Alzheimer's disease?
Dementia is an umbrella term for a decline in cognitive function severe enough to affect daily life. Alzheimer's is the most common cause. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia — each with different causes and treatments.
Are there clinical trials for non-Alzheimer's dementia?
Yes. While most dementia drug trials have focused on Alzheimer's, there is growing research into vascular dementia, Lewy body dementia, and frontotemporal dementia — including anti-inflammatory drugs, neuroprotective agents, and gene therapies.
Can someone with advanced dementia join a clinical trial?
Some trials accept participants with moderate to severe dementia, particularly those testing symptom management and quality of life interventions. A legal representative or carer would need to provide consent.
How can carers get involved in dementia research?
Many trials welcome carer involvement — from accompanying participants to joining studies about carer wellbeing, decision-making support, and technology testing. Contact your local NIHR clinical research network.
Ready to Find Your Trial?
Search thousands of actively recruiting dementia clinical trials across the UK. Our platform is free, instant, and requires no registration.